4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Senti Biosciences Holdings, Inc. (SNTI) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 39 employees. Its market capitalization is roughly $31 million. In the fiscal year ended 2025-12-31, SNTI reported $0M in revenue and ($61M) in net income.
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
Interactive charts & full statements → Open the SNTI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $2M | $3M | — |
| Operating Income (EBIT) | ($64M) | ($61M) | ($67M) | ($62M) | — |
| Net Income | ($61M) | ($53M) | ($71M) | ($58M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($14M) | ($17M) | ($17M) | ($16M) | — |
| Net Income | ($4M) | ($14M) | ($18M) | ($15M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $51M | $98M | $120M | $181M | — |
| Total Liabilities | $46M | $72M | $53M | $54M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SNTI viewer.
About TickerBase · Data methodology & sources